Product Images Galantamine
View Photos of Packaging, Labels & Appearance
- 12mg-label - 12mg label
- 4mg-label - 4mg label
- 8mg-label - 8mg label
- Chemical Structure - galantamine 01
- image description - galantamine 02
- image description - galantamine 04
- image description - galantamine 05
- image description - galantamine 06
- image description - galantamine 07
- image description - galantamine 08
- image description - galantamine 09
- image description - galantamine 10
- image description - galantamine 11
- image description - galantamine 12
- image description - galantamine 13
- Figure2 - galantamine03
Product Label Images
The following 16 images provide visual information about the product associated with Galantamine NDC 24979-724 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
12mg-label - 12mg label
This document provides details about the medication Gaaniamine hydrobromide (Galantamine) in tablet form, containing Dipense n aih, and presents its dosage information. It notes that the tablets should be stored at room temperature to maintain their efficacy and light-resistance. The manufacturer information and contact details are also given, emphasizing the need to keep the medication out of reach of children.*
4mg-label - 4mg label
8mg-label - 8mg label
Chemical Structure - galantamine 01
image description - galantamine 02
image description - galantamine 04
image description - galantamine 05
This text provides information about the Mean Change From Baseline in ADAS-cog Score after a specified period of treatment with placebo, 24 mg/day, and 32 mg/day. The data is displayed for different weeks of treatment.*
image description - galantamine 06
image description - galantamine 07
Percentage of Patients 60 50 40 = 24 = satisfied) E) 2 10 0 Most of Iodily Miroly Wb Mtc Mthy eh hhy o R e e CIBIC-plus Rating*
image description - galantamine 08
This is a description of a treatment regimen that lasts for a period of 13 weeks. The text also mentions the location as well, along with some unclear characters and symbols.*
image description - galantamine 09
image description - galantamine 10
image description - galantamine 11
image description - galantamine 12
image description - galantamine 13
Figure2 - galantamine03
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
